Half-year report · Q2
4480.TEDINET S100WJ2N
Period2025-01-01 → 2025-06-30
Filed2025-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥18.5bn | 2025-01-01 → 2025-06-30 | Cons. | Net sales |
| Revenue | ¥29.3bn | 2024-01-01 → 2024-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥14.7bn | 2024-01-01 → 2024-06-30 | Cons. | Net sales |
| Operating income | ¥1.5bn | 2025-01-01 → 2025-06-30 | Cons. | Operating income |
| Operating income | ¥2.3bn | 2024-01-01 → 2024-06-30 | Cons. | Operating income |
| Ordinary income | ¥1.6bn | 2025-01-01 → 2025-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥4.1bn | 2024-01-01 → 2024-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.2bn | 2024-01-01 → 2024-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.8bn | 2025-01-01 → 2025-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥3.2bn | 2024-01-01 → 2024-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥647m | 2025-01-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.8bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.0bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥647m | 2025-01-01 → 2025-06-30 | Cons. | Profit loss |
| Net income | ¥2.1bn | 2024-01-01 → 2024-06-30 | Cons. | Profit loss |
| Total assets | ¥47.4bn | at 2025-06-30 | Cons. | Assets |
| Total assets | ¥45.2bn | at 2024-12-31 | Cons. | Assets |
| Total assets | ¥42.2bn | at 2024-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥29.4bn | at 2025-06-30 | Cons. | Liabilities |
| Total liabilities | ¥25.0bn | at 2024-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥18.1bn | at 2025-06-30 | Cons. | Net assets |
| Net assets / equity | ¥20.2bn | at 2024-12-31 | Cons. | Net assets |
| Net assets / equity | ¥19.5bn | at 2024-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥13.5bn | at 2025-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥19.0bn | at 2024-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥13.5bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥19.0bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥20.9bn | at 2024-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥15.4bn | at 2023-12-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.9bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.4bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.5bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥6.3bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥10.7bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥8.2bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥1.1bn | 2025-01-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥11.9bn | 2024-01-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥11.1bn | 2024-01-01 → 2024-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥20.05 | 2025-01-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥86.17 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥61.9 | 2024-01-01 → 2024-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥19.95 | 2025-01-01 → 2025-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥85.62 | 2024-01-01 → 2024-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥61.5 | 2024-01-01 → 2024-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 38.1% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.7% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.1% | at 2024-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 34
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-01-01 → 2025-06-30 | −¥1m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-01-01 → 2025-06-30 | −¥1m |
| Reconciling Itemsreconciling | segment profit | 2025-01-01 → 2025-06-30 | −¥2.9bn |
| jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥4.5bn |
| jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥4.5bn |
| jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | −¥51m |
| jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥589m |
| jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥589m |
| jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segment | segment profit | 2025-01-01 → 2025-06-30 | −¥349m |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | revenue | 2025-01-01 → 2025-06-30 | ¥13.4bn |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | revenue external | 2025-01-01 → 2025-06-30 | ¥13.4bn |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥1m |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | segment profit | 2025-01-01 → 2025-06-30 | ¥4.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-01-01 → 2025-06-30 | ¥18.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-01-01 → 2025-06-30 | ¥18.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-01-01 → 2025-06-30 | ¥1m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-01-01 → 2025-06-30 | ¥4.4bn |
| Reconciling Itemsreconciling | revenue | 2024-01-01 → 2024-06-30 | −¥2m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-01-01 → 2024-06-30 | −¥2m |
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-06-30 | −¥2.2bn |
| jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥3.6bn |
| jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥3.6bn |
| jpcrp040300-q2r_E33586-000Medical Platform Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥43m |
| jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥239m |
| jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥239m |
| jpcrp040300-q2r_E33586-000New Business Development Servicesreportable segment | segment profit | 2024-01-01 → 2024-06-30 | −¥132m |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | revenue | 2024-01-01 → 2024-06-30 | ¥10.9bn |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | revenue external | 2024-01-01 → 2024-06-30 | ¥10.9bn |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥2m |
| jpcrp040300-q2r_E33586-000Recruitment Platform Businessreportable segment | segment profit | 2024-01-01 → 2024-06-30 | ¥4.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-01-01 → 2024-06-30 | ¥14.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-01-01 → 2024-06-30 | ¥14.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-01-01 → 2024-06-30 | ¥2m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-01-01 → 2024-06-30 | ¥4.5bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 534
| Item | Context | Value | Unit |
|---|---|---|---|
| Long term loans payable | CurrentQuarterInstant | 14220000000 | JPY |
| Deferred tax liabilities | Prior1YearInstant | 2629000000 | JPY |
| Deferred tax liabilities | CurrentQuarterInstant | 2552000000 | JPY |
| Other ncl | Prior1YearInstant | 224000000 | JPY |
| Other ncl | CurrentQuarterInstant | 235000000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 14418000000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 17008000000 | JPY |
| Liabilities | Prior1YearInstant | 24981000000 | JPY |
| Liabilities | CurrentQuarterInstant | 29356000000 | JPY |
| Capital stock | Prior1YearInstant | 47000000 | JPY |
| Capital stock | CurrentQuarterInstant | 47000000 | JPY |
| Capital surplus | Prior1YearInstant | 14196000000 | JPY |
| Capital surplus | CurrentQuarterInstant | 12323000000 | JPY |
| Retained earnings | Prior1YearInstant | 6601000000 | JPY |
| Retained earnings | CurrentQuarterInstant | 7248000000 | JPY |
| Treasury stock | Prior1YearInstant | -621000000 | JPY |
| Treasury stock | CurrentQuarterInstant | -1522000000 | JPY |
| Shareholders equity | Prior1YearInstant | 20223000000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 18097000000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | -40000000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | -40000000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 25000000 | JPY |
| Foreign currency translation adjustment | CurrentQuarterInstant | 8000000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | -14000000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | -32000000 | JPY |
| Non controlling interests | Prior1YearInstant | 10000000 | JPY |
| Non controlling interests | CurrentQuarterInstant | － | JPY |
| Net assets | Prior1YearInstant | 20219000000 | JPY |
| Net assets | CurrentQuarterInstant | 18065000000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 45201000000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 47422000000 | JPY |
| Net sales | Prior1YTDDuration | 14706000000 | JPY |
| Net sales | CurrentYTDDuration | 18465000000 | JPY |
| Cost of sales | Prior1YTDDuration | 5028000000 | JPY |
| Cost of sales | CurrentYTDDuration | 6969000000 | JPY |
| Gross profit | Prior1YTDDuration | 9678000000 | JPY |
| Gross profit | CurrentYTDDuration | 11496000000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 7416000000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 10034000000 | JPY |
| Operating income | Prior1YTDDuration | 2261000000 | JPY |
| Operating income | CurrentYTDDuration | 1461000000 | JPY |
| Interest income noi | Prior1YTDDuration | 0 | JPY |
| Interest income noi | CurrentYTDDuration | 8000000 | JPY |
| Settlement received noi | Prior1YTDDuration | 1163000000 | JPY |
| Settlement received noi | CurrentYTDDuration | 270000000 | JPY |
| Subsidy income noi bounty | Prior1YTDDuration | 0 | JPY |
| Subsidy income noi bounty | CurrentYTDDuration | 1000000 | JPY |
| Other noi | Prior1YTDDuration | 11000000 | JPY |
| Other noi | CurrentYTDDuration | 31000000 | JPY |
| Non operating income | Prior1YTDDuration | 1176000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |